Goldman Sachs’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.5M Buy
250,000
+63,600
+34% +$4.04M ﹤0.01% 2624
2025
Q4
$11.8M Buy
+186,400
New +$11.6M ﹤0.01% 2934
2025
Q2
Sell
-10,500
Closed -$422K 6129
2025
Q1
$422K Buy
+10,500
New +$483K ﹤0.01% 5284
2024
Q3
Sell
-19,400
Closed -$1.05M 5864
2024
Q2
$1.05M Buy
19,400
+1,400
+8% +$84.5K ﹤0.01% 4395
2024
Q1
$1.26M Buy
+18,000
New +$1.39M ﹤0.01% 4190
2017
Q4
Sell
-50,000
Closed -$725K 6388
2017
Q3
$725K Buy
+50,000
New +$683K ﹤0.01% 4838
2015
Q3
Sell
-75,000
Closed -$504K 7302
2015
Q2
$504K Hold
75,000
﹤0.01% 5204
2015
Q1
$509K Sell
75,000
-25,000
-25% -$187K ﹤0.01% 5110
2014
Q4
$801K Buy
+100,000
New +$429K ﹤0.01% 4819
2014
Q2
Sell
-451,900
Closed -$4.29M 6997
2014
Q1
$4.29M Buy
+451,900
New +$4.09M ﹤0.01% 3193

Other funds holding CYTK